Cannabinoid Synthesis via Segmented Chemical Steps
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The difficulty in conducting serious clinical trials for cannabinoids due to the lack of control over exact amounts of active ingredients in different Cannabis strains, compounded by the challenge of isolating and evaluating minor cannabinoids, necessitates a practical synthetic approach for these molecules and their analogs.
Innovation Solution
A process for synthesizing cannabinoids and their analogs, involving steps such as converting compounds of formula (II) to (III) and then to (I), using specific reagents like potassium bis(trimethylsilyl)amide and Grubbs' second generation catalyst, to produce compounds with controlled ratios and stereochemistry, facilitating the generation of novel analogs with different biological and physicochemical properties.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If cannabinoids are isolated from natural Cannabis strains, then the compounds can be obtained, but the exact amounts of active ingredients cannot be controlled and variability is high
Solution Approach 1:
The patent segments the cannabinoid synthesis into modular steps: (a) converting compound of formula (II) to compound of formula (III), and (b) converting compound of formula (III) to compound of formula (I). This segmentation allows independent optimization and control of each step, enabling precise control over final product composition and ratios.
Solution Approach 2:
The patent employs parameter changes by using specific reagents (potassium bis(trimethylsilyl)amide, Grubbs' second generation catalyst) and controlling reaction conditions to achieve precise control over stereochemistry and product ratios. This allows synthesis of cannabinoids with defined optical purity and reproducible ratios of different cannabinoids.
2Quantity of substance
If minor cannabinoids are isolated from Cannabis strains, then they can be studied, but their small quantities make isolation and study difficult
Solution Approach 1:
The patent performs preliminary synthetic action by establishing a robust synthesis route from readily available starting materials (compounds of formula II) through well-defined intermediate steps to produce minor cannabinoids in sufficient quantities. This preliminary synthesis approach enables accumulation of adequate amounts for study without relying on natural extraction.
Solution Approach 2:
The patent changes the approach from natural extraction to synthetic production, using controlled chemical transformations with specific reagents and catalysts to produce minor cannabinoids in reproducible quantities with defined stereochemistry, overcoming the limitation of small natural abundances.
3Adaptability or versatility
If different strains of Cannabis are used, then various cannabinoid profiles are obtained, but control over exact amounts of active ingredients is lost
Solution Approach 1:
The patent segments the synthesis into controlled steps that can be independently optimized, allowing precise control over which cannabinoids are produced and in what ratios. This enables reproduction of specific cannabinoid profiles while maintaining exact control over active ingredient amounts.
Solution Approach 2:
The patent creates a universal synthesis platform that can produce multiple different cannabinoid profiles by varying the starting materials and reaction conditions, rather than relying on different natural strains. This multi-functional approach maintains both versatility and precision.
4Manufacturing precision
If synthesis methods are developed for cannabinoids, then control over ratios and stereochemistry is improved, but the process complexity increases
Solution Approach 1:
The patent achieves precise control over ratios and stereochemistry by changing key reaction parameters: using potassium bis(trimethylsilyl)amide for controlled conversion of compound (II) to (III), and Grubbs' second generation catalyst for controlled conversion of (III) to (I). These specific parameter choices enable precision without excessive complexity.
Solution Approach 2:
The patent introduces compound of formula (III) as an intermediary that facilitates controlled transformation from starting material to final product. This intermediary enables stepwise control over stereochemistry and ratios, simplifying the overall process while maintaining precision.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This synthetic approach allows for the evaluation of cannabinoids as single entities or in reproducible ratios, enabling the generation of novel analogs with specific properties, thereby overcoming the challenges of variability in natural Cannabis strains and facilitating their study and application.
Implementation Method 1
converting a compound of formula (II) to a compound of formula (III)
Implementation Method 2
converting the compound of formula (III) to the compound of formula (I)
Data Source
AI summary
Provided are synthesis processes and intermediates for preparing cannabinoids and analogs.